204 - Clostridioides difficile screening among asymptomatic carriers admitted for bone marrow transplantation: Navigating optimal stewardship strategies

Thursday, October 17, 2024

3:45 PM – 4:00 PM US PT

Location: 403 A

Presenting Author(s)

Justin Hofmann, MD (he/him/his)

Infectious Diseases Fellow
Ohio State University Medical Center/Nationwide Children's Hospital
Columbus, OH, United States

Slides

Co-Author(s)

AH

Alma Habib, MD

The Ohio State University
Columbus, Ohio, United States
NT

Nikki Tran, PharmD, BCIDP

Immunocompromised Infectious Diseases Pharmacist
The Ohio State Wexner Medical Center
Columbus, Ohio, United States
SM

Sarah MacDowell, MD

The Ohio State University
Columbus, Ohio, United States
HC

Hannah Choe, MD

Ohio State University Wexner Medical Center
Columbus, Ohio, United States
CL

Christina Liscynesky, M.D.

Assistant Professor of Internal Medicine
The Ohio State Univiersity Wexner Medical Center
Columbus, Ohio, United States
Zeinab El Boghdadly, MD

Assistant Professor of Internal medicine - Division of Infectious Diseases
The Ohio State University
Columbus, OH, United States

Disclosure(s):

Justin Hofmann, MD: No financial relationships to disclose

Alma Habib, MD: No financial relationships to disclose

Nikki Tran, PharmD, BCIDP: No financial relationships to disclose

Sarah MacDowell, MD: No financial relationships to disclose

Hannah Choe, MD: Abbvie: Advisor/Consultant; Actinium: Advisor/Consultant; Incyte: Advisor/Consultant; Ironwood: Advisor/Consultant; Regimmune: Advisor/Consultant; Sanofi: Advisor/Consultant

Christina Liscynesky, M.D.: No financial relationships to disclose

Zeinab El Boghdadly, MD: No financial relationships to disclose